Thomas Smith, Pharm.D., J.D., Dean of Pharmacy and Graduate Life Sciences at Manchester University. "We are thrilled to partner with Agena Bioscience, an industry leader in the PGx space, to offer our programs to a broader audience." "Our relationship with Agena stems from the mutual goal of expanding the awareness of pharmacogenetic testing and its importance to the future of precision medicine. We believe that pharmacogenomics will increasingly enable physicians and other clinicians to prescribe the right dose of the right medicine at the right time, which ultimately leads to better healthcare outcomes. Our educational programs are aimed at producing applied scientists with opportunities for careers in the PGx laboratory industry, translational companies, and healthcare systems," stated W. Both programs are fully online and delivered by Manchester University faculty. The PGx Graduate Certificate is comprised of five courses aimed at providing in-depth education to enhance the clinical capabilities of health care professionals. The MU Master of Science in PGx program provides unparalleled depth and breadth in pharmacogenomics, covering human genetics, bioinformatics, pharmacokinetics, and more. This partnership will enable Agena Bioscience to promote and offer its customers the established MU PGx programs, including the Graduate Certificate in PGx or Master of Science in PGx degree. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences. 29, 2021 /PRNewswire/ - Agena Bioscience ® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |